Hernandez Alexandra L, Karthik Rajiv, Sivasubramanian Murugesan, Raghavendran Anantharam, Gnanamony Manu, Lensing Shelly, Lee Jeannette Y, Kannangai Rajesh, Abraham Priya, Mathai Dilip, Palefsky Joel M
*Department of Medicine, University of California, San Francisco, CA; †School of Public Health, Department of Epidemiology, University of California, Berkeley, CA; ‡Department of Medicine, Christian Medical College, Vellore, India; §The Humsafar Trust, Mumbai, India; ‖Department of Clinical Virology, Christian Medical College, Vellore, India; ¶Department of Cancer Biology and Pharmacology, University of Illinois, Chicago, IL; #Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas; and **Apollo Institute of Medical Sciences and Research, Hyderabad, India.
J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):437-43. doi: 10.1097/QAI.0000000000000855.
India has a large population of HIV-positive individuals, including men who have sex with men (MSM), and the incidence of human papillomavirus (HPV)-related cancers is high. In developed countries, HIV-positive MSM exhibit the highest prevalence of anal HPV infection and incidence of anal cancer. Little is known about anal HPV infection in HIV-positive Indian MSM.
We evaluated 300 HIV-positive MSM from 2 cities in India. Men were tested for anal HPV infection using L1-HPV DNA polymerase chain reaction with probes specific for 29 types and a mixture of 10 additional types. CD4 level and plasma HIV viral load were measured. Participants completed an interviewer-administered questionnaire including a sexual history.
The prevalence of anal HPV was 95% (95% confidence interval: 91% to 97%). The 3 most common types were HPV 35 (20%), HPV 16 (13%), and HPV 6/11 (13%). History of taking antiretroviral medications decreased risk of anal HPV 16 infection [relative risk (RR): 0.6 (0.4-1.0)]. Having an increased number of vaginal sex partners lowered risk of any anal HPV infection. Ever having receptive sex increased risk of any anal HPV [RR: 1.2 (1.1-1.4)] and anal HPV 16 [RR: 6.5 (1.8-107)].
Almost all Indian HIV-positive MSM had anal HPV infection. The prevalence of HPV 16 was lower and the prevalence of other oncogenic HPV types was higher than in similar populations in North America and Europe. Vaccine-based prevention strategies for HPV infection in India should consider potential differences in HPV type distribution among HIV-infected MSM when designing interventions.
印度有大量艾滋病毒呈阳性的人群,包括男男性行为者(MSM),且人乳头瘤病毒(HPV)相关癌症的发病率很高。在发达国家,艾滋病毒呈阳性的男男性行为者肛门HPV感染率最高,肛门癌发病率也最高。关于印度艾滋病毒呈阳性的男男性行为者的肛门HPV感染情况,人们知之甚少。
我们评估了来自印度两个城市的300名艾滋病毒呈阳性的男男性行为者。使用L1-HPV DNA聚合酶链反应,采用针对29种类型的特异性探针以及另外10种类型的混合物,对这些男性进行肛门HPV感染检测。测量CD4水平和血浆艾滋病毒病毒载量。参与者完成了一份由访谈员管理的问卷,包括性病史。
肛门HPV感染率为95%(95%置信区间:91%至97%)。最常见的3种类型是HPV 35(20%)、HPV 16(13%)和HPV 6/11(13%)。服用抗逆转录病毒药物的病史降低了肛门HPV 16感染的风险[相对风险(RR):0.6(0.4 - 1.0)]。阴道性伴侣数量增加降低了任何肛门HPV感染的风险。曾有过被动肛交增加了任何肛门HPV感染的风险[RR:1.2(1.1 - 1.4)]和肛门HPV 16感染的风险[RR:6.5(1.8 - 107)]。
几乎所有印度艾滋病毒呈阳性的男男性行为者都有肛门HPV感染。与北美和欧洲的类似人群相比,HPV 16的感染率较低,其他致癌性HPV类型的感染率较高。在印度,基于疫苗的HPV感染预防策略在设计干预措施时应考虑艾滋病毒感染的男男性行为者中HPV类型分布的潜在差异。